Molecular Detection Of Efflux Pump and Virulence Factors Genes in Pseudomonas Aeruginosa
NCT05642767 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 75
Last updated 2023-04-12
Summary
Pseudomonas aeruginosa (PA) is a ubiquitous aerobic, non-fermentative Gram-negative rod that is widely associated with nosocomial pneumonia and can lead to severe illness with poor outcomes, particularly in critically ill people due to the ability of some strains to cause lung epithelial injury and spread into the circulation. 2 In the intensive care unit, PA infection is ranked among the top five causes of the bloodstream, pulmonary, surgical site, urinary tract, and soft tissue infections.
Conditions
- Pseudomonas Aeruginosa
Interventions
- DIAGNOSTIC_TEST
-
culture on cetrimide agar
Samples will be inoculated on cetrimide agar using the plating out technique.
- DIAGNOSTIC_TEST
-
Staining with Gram stain
colonies on cetrimide agar will be spread on glass slide and stained by gram stain
- DIAGNOSTIC_TEST
-
Antibiotic sensitivity testing
Antibiotic sensitivity testing will be done by disc diffusion method according to CLSI
- DIAGNOSTIC_TEST
-
Molecular detection to efflux genes and some virulence genes
Molecular detection to efflux genes and some virulence genes by conventional PCR
Sponsors & Collaborators
-
Sohag University
lead OTHER
Principal Investigators
-
Mohamed H Alrawy · Faculty of medicine, Sohag university
-
Ebtisam M Gad · Faculty Of Medicine, Sohag university
Eligibility
- Min Age
- 4 Weeks
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-12-01
- Primary Completion
- 2023-03-30
- Completion
- 2023-05-01
Countries
- Egypt
Study Locations
More Related Trials
-
How COVID-19 Virus Outbreak Affects Antimicrobial Resistance in a Low-middle-income Country's ICU?
NCT04348227 ·Status: UNKNOWN
-
Impact of BacT/Alert® VIRTUO®, BioFire® Blood Culture Identification 2-BCID2 and REVEAL® (bioMérieux) on the Optimization of Antibiotic Therapy for Gram-negative Bacteremia in the ICU
NCT05741424 ·Status: COMPLETED ·Phase: NA
-
Direct E-test on Bronchoalveolar Lavage From Patients With Ventilator-acquired Pneumonia
NCT01042353 ·Status: COMPLETED ·Phase: PHASE4
-
Lipid Kinetics of Patients With Pneumonia
NCT04748432 ·Status: COMPLETED
-
Microbiological Profile of VAP Patients in Respiratory ICU
NCT05738928 ·Status: UNKNOWN
-
Antibiotic Treatment for Pneumonia Caused by Stenotrophomonas Maltophilia in ICU Patients
NCT07052604 ·Status: RECRUITING
-
Bilateral Bronchoalveolar Lavage in Ventilator-associated Pneumonia
NCT02542553 ·Status: COMPLETED ·Phase: NA
-
Empiric Antibiotic Therapy for Ventilator-acquired Pneumonia With Gram-negative Bacilli in Intensive Care
NCT02127528 ·Status: UNKNOWN
-
A Cohort Study on Anti-microbial Stewardship in PICU
NCT05862688 ·Status: NOT_YET_RECRUITING
-
Prognosis and Virulence Determination of Capsule and Endotoxin During Klebsiella Spp. Ventilator-associated Pneumonias
NCT05450796 ·Status: UNKNOWN
-
Antibiograms of Intensive Care Units at an Egyptian Tertiary Care Hospital
NCT04318613 ·Status: COMPLETED
-
Value of Infection Control Programs on Infection Associated with Urinary Tract Catheterization in Sohag University Hospital
NCT06859814 ·Status: RECRUITING ·Phase: NA
-
Advanced Understanding of Staphylococcus Aureus and Pseudomonas Aeruginosa Infections in EuRopE - ICU
NCT02413242 ·Status: COMPLETED
-
Pulmonary Diffusion of Antibiotics in Patients Admitted for ARDS Following SARS-CoV-2 Pneumonia
NCT05464680 ·Status: COMPLETED ·Phase: NA
-
Confirmatory Phase II/III Study Assessing Efficacy, Immunogenicity and Safety of IC43
NCT01563263 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Impact of Oral Care on Ventilator Associated Pneumonia
NCT07287566 ·Status: COMPLETED ·Phase: NA
-
The Pharmacodynamics of Doripenem Between 4-hour and 1-hour Infusion in Patients With Ventilator-associated Pneumonia
NCT01467648 ·Status: COMPLETED ·Phase: PHASE4
-
Impact of Antimicrobial Stewardship on Outcomes of Patients With Hospital-acquired Pneumonia Due to Gram-negative Bacilli - A Before-after Study
NCT04937075 ·Status: COMPLETED
-
WHO Checklist- Based Infection Prevention Guidelines in Mulago Hospital
NCT03822039 ·Status: UNKNOWN
-
Nebulized Amikacin Versus Intravenous Amikacin in the Treatment of Nosocomial Pneumonia
NCT02728518 ·Status: COMPLETED ·Phase: NA
-
Gram-negative Bacilli and MRSA Screening in ICU in China
NCT04310722 ·Status: UNKNOWN
-
Nurse-led Antimicrobial Stewardship Intervention to Increase Antibiotic Appropriateness in Residential Aged Care Facilities
NCT03941509 ·Status: UNKNOWN ·Phase: NA
-
Implementing Oral Care Bundle on Critical Care Nurses' Practice and Mechanically Ventilated Patients' Outcomes
NCT05351619 ·Status: UNKNOWN ·Phase: NA
-
Nosocomial Infections in ECMO Patients
NCT05566665 ·Status: RECRUITING
-
Aerosolized Colistin to Mechanical Ventilated Patients With Pneumonia
NCT04633317 ·Status: COMPLETED ·Phase: NA